Screening compound: C20H25N5O2S (S661-1270)

Screening compound: C<sub>20</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>S (S661-1270)
Screening compound: C<sub>20</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>S (S661-1270) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C20H25N5O2S (S661-1270)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S661-1270

Molecular Formula

C20H25N5O2S (C20 H25 N5 O2 S)

Compound Name

2'-ethyl-1-{[3-(thiophen-2-yl)-1H-pyrazol-4-yl]methyl}-hexahydrospiro[piperidine-4,6'-pyrrolo[1,2-c]imidazole]-1',3'-dione

IUPAC name

2'-ethyl-1-{[3-(thiophen-2-yl)-1H-pyrazol-4-yl]methyl}-hexahydrospiro[piperidine-46'-pyrrolo[12-c]imidazole]-1'3'-dione

SMILES

CCN(C(C(C1)N2CC11CCN(Cc3c[nH]nc3-c3cccs3)CC1)=O)C2=O

InChI

InChI=1S/C20H25N5O2S/c1-2-24-18(26)15-10-20(13-25(15)19(24)27)5-7-23(8-6-20)12-14-11-21-22-17(14)16-4-3-9-28-16/h3-4,9,11,15H,2,5-8,10,12-13H2,1H3,(H,21,22)/t15-/m1/s1

InChI Key

RJCBSJMEIQONTQ-OAHLLOKOSA-N

MDL Number (MFCD)

MFCD30460710

C20H25N5O2S (S661-1270) in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C20H25N5O2S (S661-1270) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C20H25N5O2S (S661-1270)?
Check Price and Availability of C20H25N5O2S (S661-1270), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C20H25N5O2S (S661-1270) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C20H25N5O2S (S661-1270)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C20H25N5O2S (S661-1270)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C20H25N5O2S (S661-1270) available by request